• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 HNMR 的恶性和良性胸腔积液代谢组学图谱的差异。

Differences in HNMR Based Metabolomic Patterns of Malignant and Benign Pleural Effusions.

机构信息

Department of Respiratory and Critical Care Medicine, The Fifth People's Hospital of Jingdezheng City, Jingdezheng, China.

Department of Respiratory and Critical Care Medicine, The Second People's Hospital of Jingdezheng City, Jingdezheng, China

出版信息

Ann Clin Lab Sci. 2024 Mar;54(2):201-210.

PMID:38802158
Abstract

OBJECTIVE

Malignant pleural effusion (MPE) is a common complication of lung cancer with poor prognosis. Benign pleural effusion (BPE), such as tuberculous and pneumonic pleural effusion, usually has a good prognosis. Differential diagnosis between MPE and BPE remains a clinical challenge.

METHODS

52 MPE, 93 BPE, and their corresponding serum samples were analyzed by hydrogen nuclear magnetic resonance (HNMR) based metabolomics.

RESULTS

The HNMR study showed that some amino acids and betaine in MPE are significantly altered in pleural effusion and serum compared to BPE patients. Levels of serum glucose and glutamine have strong positive correlation with those in pleural effusion (r>0.6) for MPE patients. The area under the receiver operating characteristic curve (AUROC) values of metabolites in pleural effusion or serum were less than 0.805 in differentiating MPE from BPE. Improved an AUROC value of 0.901 was observed using pleural effusion-serum ratios of glutamic acid in differentiating MPE from BPE, which was further validated by 15 double-blind samples.

CONCLUSIONS

Compared with BPE patients, amino acids and betaine in MPE are significantly altered in pleural effusion and serum. Pleural effusion-serum ratio of glutamic acid may contribute to the rapid diagnosis of MPE from BPE by HNMR analysis.

摘要

目的

恶性胸腔积液(MPE)是肺癌的常见并发症,预后不良。良性胸腔积液(BPE),如结核性和肺炎性胸腔积液,通常预后良好。MPE 和 BPE 的鉴别诊断仍然是临床挑战。

方法

对 52 例 MPE、93 例 BPE 及其相应的血清样本进行基于氢核磁共振(HNMR)的代谢组学分析。

结果

HNMR 研究表明,与 BPE 患者相比,MPE 患者胸腔积液和血清中的一些氨基酸和甜菜碱明显改变。MPE 患者血清葡萄糖和谷氨酰胺水平与胸腔积液中的水平呈强正相关(r>0.6)。区分 MPE 和 BPE 时,胸腔积液或血清中代谢物的受试者工作特征曲线(AUROC)值小于 0.805。使用区分 MPE 和 BPE 的胸腔积液-血清谷氨酸比值可提高 AUROC 值至 0.901,这在 15 个双盲样本中得到了进一步验证。

结论

与 BPE 患者相比,MPE 患者胸腔积液和血清中的氨基酸和甜菜碱明显改变。HNMR 分析显示,胸腔积液-血清谷氨酸比值可能有助于快速诊断 MPE 与 BPE。

相似文献

1
Differences in HNMR Based Metabolomic Patterns of Malignant and Benign Pleural Effusions.基于 HNMR 的恶性和良性胸腔积液代谢组学图谱的差异。
Ann Clin Lab Sci. 2024 Mar;54(2):201-210.
2
Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.SiSo细胞表达的可溶性受体结合癌抗原和癌胚抗原在鉴别恶性与良性胸腔积液中的诊断价值
Tumour Biol. 2016 Mar;37(3):3257-64. doi: 10.1007/s13277-015-4174-8. Epub 2015 Oct 5.
3
Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.定量蛋白质组学揭示了可区分恶性胸腔积液和良性胸腔积液的蛋白质生物标志物。
J Proteomics. 2024 Jun 30;302:105201. doi: 10.1016/j.jprot.2024.105201. Epub 2024 May 18.
4
Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.评估血清和胸腔积液中的一组 microRNA 用于良恶性胸腔积液的鉴别诊断。
Cancer Biomark. 2022;33(1):71-82. doi: 10.3233/CBM-210090.
5
Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.1,230 例患者中六种肿瘤标志物对恶性胸腔积液的诊断价值:一项单中心回顾性研究。
Pathol Oncol Res. 2022 Apr 20;28:1610280. doi: 10.3389/pore.2022.1610280. eCollection 2022.
6
[The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].[B7-H4与癌胚抗原在诊断良恶性胸腔积液中的价值]
Zhonghua Zhong Liu Za Zhi. 2017 Jul 23;39(7):524-527. doi: 10.3760/cma.j.issn.0253-3766.2017.07.009.
7
Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.降钙素原和C反应蛋白检测在鉴别良恶性胸腔积液中的有效性。
Clin Lab. 2011;57(5-6):373-8.
8
Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.组织蛋白酶 D 前体作为鉴别良恶性胸腔积液的诊断标志物:一项回顾性队列研究。
BMC Cancer. 2020 Aug 31;20(1):825. doi: 10.1186/s12885-020-07327-w.
9
Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.可溶性B7-H4和癌胚抗原在鉴别恶性与良性胸腔积液中的诊断价值。
Clin Respir J. 2018 Mar;12(3):986-990. doi: 10.1111/crj.12615. Epub 2017 Feb 13.
10
Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.鉴定和诊断非小细胞肺癌患者恶性胸腔积液中胸膜蛋白多糖和血清蛋白多糖的价值。
J Clin Lab Anal. 2019 Sep;33(7):e22943. doi: 10.1002/jcla.22943. Epub 2019 Jul 3.